Professor Mustafa Solak brings international expertise to Hisar Hospital Intercontinental, having completed a fellowship at the University of Texas MD Anderson Cancer Center – arguably the world's most famous cancer hospital.
Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.
Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.
Professor Sezer Sağlam is a senior medical oncologist at Gayrettepe Florence Nightingale Hospital, where he leads the management of complex solid tumours.
Top Turkish oncology centres prioritise active surveillance and systemic therapies over surgery to manage desmoid tumours. Specialists at JCI-accredited facilities, including Anadolu Medical Center and Memorial Health Group, follow international NCCN and ESMO protocols. They focus on non-invasive modalities like targeted therapies and precision radiotherapy to minimise recurrence.
Bookimed Expert Insight: Turkish oncology centres stand out by combining academic affiliation with high-volume surgical expertise. Anadolu Medical Center is affiliated with Johns Hopkins Medicine. This gives them access to global sarcoma protocols. Memorial Antalya Hospital treats 1.6 million patients annually, with 80% of cancer cases receiving TrueBeam STx radiotherapy. This volume allows multidisciplinary boards to accurately predict when to switch from surveillance to active intervention.
Patient Consensus: Patients emphasise that active surveillance is often the first step in Turkey because desmoids can spontaneously regress. Many find relief through oral targeted therapies like sorafenib. These can shrink tumours and quickly reduce pressure symptoms.
Anadolu Medical Center and Memorial Bahçelievler are leading Turkish hospitals for desmoid tumour treatment. These centres use multidisciplinary sarcoma boards to plan care. They offer therapies like MR-LINAC, targeted drugs, and precision surgery. Most facilities hold JCI accreditation for international safety.
Bookimed Expert Insight: Turkish oncology centres like Hisar Hospital Intercontinental stand out by offering MR-LINAC technology. This is vital for desmoid tumours because it allows specialists to track tumour movement in real-time. Since desmoids often sit near organs, this precision prevents damage to healthy tissue. Choosing a centre with MR-LINAC or TrueBeam STx allows the most conservative, tissue-sparing approach possible.
Patient Consensus: Patients note that finding a sarcoma specialist is more important than the hospital brand alone. They often suggest starting with a consultation at large academic centres in Istanbul or Ankara. This helps confirm whether surgery or monitoring is better.
Patients choose Turkey for desmoid tumour treatment because of high-volume oncology centres and multidisciplinary sarcoma expertise. Leading facilities hold JCI accreditation. They follow international NCCN and ESMO protocols. Specialist teams offer advanced diagnostics and targeted therapies. These are often unavailable or subject to long waiting lists elsewhere.
Bookimed Expert Insight: While many search for surgical options, Turkey’s strength lies in multidisciplinary boards. Here, medical and radiation oncologists collaborate. For example, Anadolu Medical Center integrates interventional oncology standards (IASIOS) into rare tumour management. This allows for tailored treatment plans. These may combine systemic therapies with precision radiation, rather than relying solely on surgery.
Patient Consensus: Patients note that finding a sarcoma specialist is vital. Desmoids require long-term management rather than a one-off cure. Many in Turkey find relief through systemic treatments like sorafenib or targeted radiation when surgery is not the primary option.